Risk factors for healthcare-associated Clostridium difficile infection in pediatric hematopoietic stem cell transplant recipients

1305. External validation of predictive scores for mortality following Clostridium difficile infection Catherine Beauregard-Paultre, MD; Claire Nour Abou Chakra, PhD; Allison Mcgeer, MD, MSc; Annie-Claude Labbé, MD; Andrew E. Simor, MD, FRCPC, FACP; Wayne Gold, MD; Matthew P. Muller, MD, PhD, FRCPC; Jeff Powis, MD, MSc, FRCPC; Kevin Katz, MD, CM, MSc, FRCPC; Suzanne Cadarette, PhD; Jacques Pépin, MD; Julian R. Garneau, MSc and Louis Valiquette, MD, MSc, FRCPC; Microbiology and Infectious Disease, Université de Sherbrooke, Sherbrooke, QC, Canada, Infection Control, University of Toronto, Toronto, ON, Canada, Microbiology, CIUSSS de l’est-del’île-de-Montréal, Montreal, QC, Canada, Microbiology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, Toronto General Hospital, Toronto, ON, Canada, Medicine, St.Michael’s Hospital, Toronto, ON, Canada, Michael Garron Hospital, Toronto, ON, Canada, Department of Infection Control, North York General Hospital, Toronto, ON, Canada, University of Toronto, Toronto, ON, Canada, Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada